GAMMA Investing »

Nautilus Biotechnology shares owned by GAMMA Investing

Quarter-by-quarter ownership of Nautilus Biotechnology (NAUT) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Nautilus Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Nautilus Biotechnology held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nautilus Biotechnology by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2024-03-31 $309 105 2.94
2023-12-31 $292 105 2.78

More positions owned by GAMMA Investing

Microsoft Corp Common Stock (MSFT)
Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Ishares Tr National Mun Etf Etf (MUB)
Visa Inc Com Cl A Common Stock (V)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Inc Core Msci Emkt Etf (IEMG)
Eli Lilly Common Stock (LLY)
Home Depot Common Stock (HD)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)

View all positions for GAMMA Investing

Top funds holding Nautilus Biotechnology

AH Capital Management
Perceptive Advisors
Cercano Management
Madrona Venture Group
Vanguard Group
Comprehensive Financial Management
Amazon
Clarius
Alyeska Investment Group
Dimensional Fund Advisors
Clearline Capital
Hillman
Bank of New York Mellon
Charles Schwab Investment Management
Citadel Advisors

View all funds holding Nautilus Biotechnology